These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1719394)

  • 21. Comparison of DNA interstrand cross-linking and strand breakage by 1,3-bis(2-chloroethyl)-1-nitrosourea in polyamine-depleted and control human adenocarcinoma cells.
    Seidenfeld J; Barnes D; Block AL; Erickson LC
    Cancer Res; 1987 Sep; 47(17):4538-43. PubMed ID: 3113720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure activity analysis of the formation of DNA damage induced in human tumor cells by the cyclodisone class of anti-tumor agent.
    Berardini MD; Pacheco DY; Gibson NW
    Anticancer Drug Des; 1991 May; 6(2):119-27. PubMed ID: 2039582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.
    Giaccone G; Gazdar AF; Beck H; Zunino F; Capranico G
    Cancer Res; 1992 Apr; 52(7):1666-74. PubMed ID: 1312895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines.
    Buller AL; Clapper ML; Tew KD
    Mol Pharmacol; 1987 Jun; 31(6):575-8. PubMed ID: 3600602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The toxicity and mutagenicity of the anti-tumour drug 5-aziridino-2,4-dinitrobenzamide (CB1954) is greatly reduced in a nitroreductase-deficient strain of E. coli.
    Venitt S; Crofton-Sleigh C
    Mutagenesis; 1987 Sep; 2(5):375-81. PubMed ID: 3325769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate.
    Hill BT; Shellard SA; Hosking LK; Dempke WC; Fichtinger-Schepman AM; Tone T; Scanlon KJ; Whelan RD
    Cancer Res; 1992 Jun; 52(11):3110-8. PubMed ID: 1591724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance.
    Li L; Keating MJ; Plunkett W; Yang LY
    Mol Pharmacol; 1997 Nov; 52(5):798-806. PubMed ID: 9351970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a glutathione S-transferase associated with microsomes of tumor cells resistant to nitrogen mustards.
    Clapper ML; Tew KD
    Biochem Pharmacol; 1989 Jun; 38(12):1915-21. PubMed ID: 2742599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation and repair of 1,3-bis-(2-chloroethyl)-1-nitrosourea and cisplatin induced total genomic DNA interstrand crosslinks in human glioma cells.
    Ali-Osman F; Rairkar A; Young P
    Cancer Biochem Biophys; 1995 Jan; 14(4):231-41. PubMed ID: 7767897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific DNA repair mechanisms may protect some human tumor cells from DNA interstrand crosslinking by chloroethylnitrosoureas but not from crosslinking by other anti-tumor alkylating agents.
    Gibson NW; Zlotogorski C; Erickson LC
    Carcinogenesis; 1985 Mar; 6(3):445-50. PubMed ID: 3978757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA interstrand cross-linking and cytotoxicity induced by chloroethylnitrosoureas and cisplatin in human glioma cell lines which vary in cellular concentration of O6-alkylguanine-DNA alkyltransferase.
    Beith J; Hartley J; Darling J; Souhami R
    Br J Cancer; 1997; 75(4):500-5. PubMed ID: 9052400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inherent sensitivity of cultured human embryonal carcinoma cells to adducts of cis-diamminedichloroplatinum(II) on DNA.
    Pera MF; Friedlos F; Mills J; Roberts JJ
    Cancer Res; 1987 Dec; 47(24 Pt 1):6810-3. PubMed ID: 3677108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-proliferative activity and mechanism of action of titanocene dichloride.
    Christodoulou CV; Eliopoulos AG; Young LS; Hodgkins L; Ferry DR; Kerr DJ
    Br J Cancer; 1998 Jun; 77(12):2088-97. PubMed ID: 9649119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential sensitivity of histone acetylation in nitrogen-mustard sensitive and resistant cells. Relation to drug uptake, formation and repair of DNA-interstrand cross-links.
    Helliger W; Hofmann J; Maly K; Doppler W; Hermann BJ; Höck W; Puschendorf B; Grunicke H
    Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1861-8. PubMed ID: 3220083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers.
    Lombardi AJ; Hoskins EE; Foglesong GD; Wikenheiser-Brokamp KA; Wiesmüller L; Hanenberg H; Andreassen PR; Jacobs AJ; Olson SB; Keeble WW; Hays LE; Wells SI
    Clin Cancer Res; 2015 Apr; 21(8):1962-72. PubMed ID: 25609062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of cultured human cell lines from rhabdomyosarcoma xenografts to treatment with chloroethylnitrosoureas.
    Smith DG; Brent TP
    Cancer Res; 1989 Feb; 49(4):883-6. PubMed ID: 2521455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased sensitivity to cisplatin by nm23-transfected tumor cell lines.
    Ferguson AW; Flatow U; MacDonald NJ; Larminat F; Bohr VA; Steeg PS
    Cancer Res; 1996 Jul; 56(13):2931-5. PubMed ID: 8674043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene and human tumour cell line specific differencesin nitrogen mustard induced DNA alkylation and interstrand crosslinking frequencies.
    Sunters A; Grimaldi KA; Souhami RL; Hartley JA
    Nucleic Acids Res; 1998 Dec; 26(24):5617-23. PubMed ID: 9837991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
    Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR
    Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
    Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.